These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25955166)

  • 1. A new report of FVII-inhibitor in a patient suffering from severe congenital FVII deficiency.
    Borhany M; Delbes C; Giansily-Blaizot M; Zubair M; Ahmed MS; Fatima N; Shamsi T
    Haemophilia; 2015 Jul; 21(4):e336-8. PubMed ID: 25955166
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII.
    Tokgoz H; Caliskan U; Lavigne-Lissalde G; Giansily-Blaizot M
    Haemophilia; 2012 Jan; 18(1):e25-7. PubMed ID: 21973016
    [No Abstract]   [Full Text] [Related]  

  • 3. A rare combination: congenital factor VII deficiency with Chiari malformation.
    Bay A; Aktekin E; Erkutlu I
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):946-8. PubMed ID: 26248161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VII deficiency: defining the clinical picture and optimizing therapeutic options.
    Lapecorella M; Mariani G;
    Haemophilia; 2008 Nov; 14(6):1170-5. PubMed ID: 19141157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report.
    Sun Y; Jia L; Yang Z; Chen W
    Medicine (Baltimore); 2018 Nov; 97(44):e12776. PubMed ID: 30383632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isotypic analysis of antibodies against activated Factor VII in patients with Factor VII deficiency using the x-MAP technology.
    Pfeiffer C; Mathieu-Dupas E; Logghe P; Lissalde-Lavigne G; Balicchi J; Caliskan U; Valentin T; Laune D; Molina F; Schved JF; Giansily-Blaizot M
    Thromb Res; 2016 May; 141():22-7. PubMed ID: 26962982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factor VII variants resistant to inhibitory antibodies.
    Branchini A; Baroni M; Pfeiffer C; Batorova A; Giansily-Blaizot M; Schved JF; Mariani G; Bernardi F; Pinotti M
    Thromb Haemost; 2014 Nov; 112(5):972-80. PubMed ID: 25104096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients.
    Shams M; Dorgalaleh A; Safarian N; Emami AH; Zaker F; Tabibian S; Managhchi MR; Faranoush M; Tabatabaei T; Satari S; Rezvani MR
    Blood Coagul Fibrinolysis; 2019 Jan; 30(1):24-28. PubMed ID: 30585836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII.
    İnce Z; Bulut Ö; Tuğrul-Aksakal M; Ünüvar A; Devecioğlu Ö; Çoban A
    Turk J Pediatr; 2018; 60(5):562-565. PubMed ID: 30968639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant activated factor VII in approved indications: Update on safety.
    Neufeld EJ; Négrier C; Benchikh El Fegoun S; Cooper DL; Rojas-Rios A; Seremetis S
    Haemophilia; 2018 Jul; 24(4):e275-e277. PubMed ID: 30004625
    [No Abstract]   [Full Text] [Related]  

  • 11. Pregnancy in women with congenital factor VII deficiency.
    Kulkarni AA; Lee CA; Kadir RA
    Haemophilia; 2006 Jul; 12(4):413-6. PubMed ID: 16834743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenicity of activated recombinant factor VII followed through nine years of clinical experience.
    Nicolaisen EM
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S119-23. PubMed ID: 9819042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report].
    Comes JF; Devignes J; Thiebaugeorges O; Briquel ME; Lecompte T
    Ann Biol Clin (Paris); 2011; 69(6):713-9. PubMed ID: 22123573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect.
    Morfini M; Batorova A; Mariani G; Auerswald G; Bernardi F; Di Minno G; Dolce A; Fede C; Giansily-Blaizot M; Ingerslev J; Martinowitz U; Napolitano M; Pinotti M; Schved JF;
    Thromb Haemost; 2014 Aug; 112(2):424-5. PubMed ID: 24763923
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency.
    Tcheng WY; Donkin J; Konzal S; Wong WY
    Haemophilia; 2004 May; 10(3):295-8. PubMed ID: 15086331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Labour and Delivery in a Patient With Acquired Factor VII Deficiency With Inhibitor: A Case Report.
    Matei A; Dolan S; Andrews J; Rivard GÉ
    J Obstet Gynaecol Can; 2016 Feb; 38(2):160-3. PubMed ID: 27032741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review.
    Loddo A; Cornacchia S; Cane FL; Barcellona D; Marongiu F; Melis GB; Angioni S; Paoletti AM; Neri M
    Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():77-80. PubMed ID: 30831446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients.
    van Geffen M; Mathijssen NC; Holme PA; Laros-van Gorkom BA; van Kraaij MG; Masereeuw R; Peyvandi F; van Heerde WL
    Thromb Res; 2013 Jul; 132(1):116-22. PubMed ID: 23731565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated recombinant activated factor VII administration in a patient with congenital factor VII deficiency undergoing modified radical hysterectomy: a case report.
    Shirasawa H; Yoshioka T; Sawada K; Terada Y
    Haemophilia; 2014 Jan; 20(1):e101-3. PubMed ID: 24261688
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency.
    White B; O'Connor H; Smith OP
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):155-7. PubMed ID: 10759008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.